250 related articles for article (PubMed ID: 9709808)
1. Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion.
Taipale J; Saharinen J; Keski-Oja J
Adv Cancer Res; 1998; 75():87-134. PubMed ID: 9709808
[TBL] [Abstract][Full Text] [Related]
2. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.
Hyytiäinen M; Penttinen C; Keski-Oja J
Crit Rev Clin Lab Sci; 2004; 41(3):233-64. PubMed ID: 15307633
[TBL] [Abstract][Full Text] [Related]
3. Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.
Saharinen J; Hyytiäinen M; Taipale J; Keski-Oja J
Cytokine Growth Factor Rev; 1999 Jun; 10(2):99-117. PubMed ID: 10743502
[TBL] [Abstract][Full Text] [Related]
4. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein.
Taipale J; Miyazono K; Heldin CH; Keski-Oja J
J Cell Biol; 1994 Jan; 124(1-2):171-81. PubMed ID: 8294500
[TBL] [Abstract][Full Text] [Related]
5. Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.
Taipale J; Saharinen J; Hedman K; Keski-Oja J
J Histochem Cytochem; 1996 Aug; 44(8):875-89. PubMed ID: 8756760
[TBL] [Abstract][Full Text] [Related]
6. Latent TGF-β-binding proteins.
Robertson IB; Horiguchi M; Zilberberg L; Dabovic B; Hadjiolova K; Rifkin DB
Matrix Biol; 2015 Sep; 47():44-53. PubMed ID: 25960419
[TBL] [Abstract][Full Text] [Related]
7. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
8. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
Saharinen J; Taipale J; Keski-Oja J
EMBO J; 1996 Jan; 15(2):245-53. PubMed ID: 8617200
[TBL] [Abstract][Full Text] [Related]
9. Different expression of transforming growth factor beta 1 in pancreatic ductal adenocarcinoma and cystic neoplasms.
Van Laethem JL; Resibois A; Rickaert F; Devière J; Gelin M; Cremer M; Robberecht P
Pancreas; 1997 Jul; 15(1):41-7. PubMed ID: 9211491
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.
Sterner-Kock A; Thorey IS; Koli K; Wempe F; Otte J; Bangsow T; Kuhlmeier K; Kirchner T; Jin S; Keski-Oja J; von Melchner H
Genes Dev; 2002 Sep; 16(17):2264-73. PubMed ID: 12208849
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.
Saharinen J; Taipale J; Monni O; Keski-Oja J
J Biol Chem; 1998 Jul; 273(29):18459-69. PubMed ID: 9660815
[TBL] [Abstract][Full Text] [Related]
12. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1.
Tatti O; Vehviläinen P; Lehti K; Keski-Oja J
Exp Cell Res; 2008 Aug; 314(13):2501-14. PubMed ID: 18602101
[TBL] [Abstract][Full Text] [Related]
13. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta.
Nunes I; Gleizes PE; Metz CN; Rifkin DB
J Cell Biol; 1997 Mar; 136(5):1151-63. PubMed ID: 9060478
[TBL] [Abstract][Full Text] [Related]
14. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
15. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1.
Annes JP; Chen Y; Munger JS; Rifkin DB
J Cell Biol; 2004 Jun; 165(5):723-34. PubMed ID: 15184403
[TBL] [Abstract][Full Text] [Related]
16. Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells.
Hori Y; Katoh T; Hirakata M; Joki N; Kaname S; Fukagawa M; Okuda T; Ohashi H; Fujita T; Miyazono K; Kurokawa K
Kidney Int; 1998 Jun; 53(6):1616-25. PubMed ID: 9607192
[TBL] [Abstract][Full Text] [Related]
17. Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy.
Tamaki K; Okuda S; Miyazono K; Nakayama M; Fujishima M
Lab Invest; 1995 Jul; 73(1):81-9. PubMed ID: 7603044
[TBL] [Abstract][Full Text] [Related]
18. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
19. Extracellular fibrillar structure of latent TGF beta binding protein-1: role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart.
Nakajima Y; Miyazono K; Kato M; Takase M; Yamagishi T; Nakamura H
J Cell Biol; 1997 Jan; 136(1):193-204. PubMed ID: 9008713
[TBL] [Abstract][Full Text] [Related]
20. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
Roth S; Schurek J; Gressner AM
Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
